EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access · CC BY-NC 4.0

Respiratory Syncytial Virus Vaccination Is Associated With Increased Odds of Preterm Birth

Ilari Kuitunen iD, Marjut Haapanen

Acta Paediatrica · 2026

DOI: 10.1111/apa.17595 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Paediatrica, 2026. Verfasst von Ilari Kuitunen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine and Kuopio Pediatric Research Unit (KUPRU), University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Premature Birth, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Vaccination. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lastentautien Tutkimussäätiö, Suomen Kulttuurirahasto, Orionin Tutkimussäätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To analyse whether respiratory syncytial virus (RSV) vaccination during pregnancy increases the odds of preterm birth.

Methods

A rapid review and meta‐analysis was performed. The main outcome was the risk of preterm (gestational week less than 37) birth. A fixed‐effects model was used to analyse pooled odds ratios (OR) with 95% confidence intervals (CI). Evidence certainty was assessed according to GRADE.

Results

We included six randomised controlled trials with 17 656 births and two observational studies with 3446 births. The odds for preterm birth were increased in the randomised studies (OR 1.17, CI 1.02–1.34). No evidence of a difference was seen in the observational studies (OR 0.93, CI 0.69–1.25). Combined, these showed increased odds for preterm birth (OR 1.13, CI 1.00–1.27). Evidence certainty was rated to be moderate. When restricted to market‐approved vaccine, the odds seemed to be increased in RCTs (OR 1.21, CI 0.98–1.49).

Conclusion

Based on the available evidence, RSV vaccination seems to be associated with increased odds for preterm birth. RSV vaccination needs continuous population‐level observational safety data monitoring on the perinatal outcomes during the early phases of vaccine rollouts to detect possible safety signals and further confirm the magnitude of the effect on preterm birth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesVaccinationHumansFemalePregnancyInfant, Newborn

Stichwörter der Autor:innen

RSVneonatologyperinatologypreterm birthvaccination

Substanzen

Respiratory Syncytial Virus Vaccines

Autor:innen und Institutionen

  • Institute of Clinical Medicine and Kuopio Pediatric Research Unit (KUPRU), University of Eastern Finland, Kuopio, Finland.
  • Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland.
  • Department of Obstetrics, Mikkeli Central Hospital, Mikkeli, Finland.

ORCID-Profile: Ilari Kuitunen

Förderung

  • Lastentautien Tutkimussäätiö
  • Suomen Kulttuurirahasto
  • Orionin Tutkimussäätiö

Zitieren

APA

Kuitunen, I., & Haapanen, M. (2026). Respiratory Syncytial Virus Vaccination Is Associated With Increased Odds of Preterm Birth. Acta Paediatrica. https://doi.org/10.1111/apa.17595

Vancouver

Kuitunen I, Haapanen M. Respiratory Syncytial Virus Vaccination Is Associated With Increased Odds of Preterm Birth. Acta Paediatrica. 2026. doi:10.1111/apa.17595

BibTeX
@article{Kuitunen2026,
  author = {Kuitunen, Ilari and Haapanen, Marjut},
  title = {Respiratory Syncytial Virus Vaccination Is Associated With Increased Odds of Preterm Birth},
  journal = {Acta Paediatrica},
  year = {2026},
  doi = {10.1111/apa.17595}
}
Kostenlos starten →